Furthermore, experimental autoimmune encephalomyelitis (EAE) studies imply that LCN2 is a critical mediator of autoimmune inflammation and disease development in this model of MS (Berard et al. 2012; Nam et al. 2014). This evidence concerns the gene LCN2 and myeloid sarcoma.